Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Allergy and Immunology

Vaccine/Immunotherapy

Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013–2014 season

Vaccine | Feb 21, 2018 Vaccine/Immunotherapy

Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013–2016

Vaccine | Feb 21, 2018 Vaccine/Immunotherapy

Impact of adverse event solicitation on the safety profile of SQ house dust mite sublingual immunotherapy tablet

The Journal of Allergy and Clinical Immunology: In Practice | Feb 16, 2018 Vaccine/Immunotherapy

Mogamulizumab (anti-CCR4) in HTLV-1–associated myelopathy

New England Journal of Medicine | Feb 15, 2018 Vaccine/Immunotherapy

Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a previous dose

Journal of the Pediatric Infectious Diseases Society | Feb 14, 2018 Vaccine/Immunotherapy

Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism

International Journal of Epidemiology | Feb 12, 2018 Vaccine/Immunotherapy

High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females

The Journal of Infectious Diseases | Feb 12, 2018 Vaccine/Immunotherapy

Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination

The Journal of Infectious Diseases | Feb 12, 2018 Vaccine/Immunotherapy

No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: Experience from a single centre

Archives of Gynecology and Obstetrics | Feb 08, 2018 Vaccine/Immunotherapy

Safety and immunogenicity of newborn MVA85A vaccination and selective, delayed bacille Calmette-Guérin for infants of human immunodeficiency virus-infected mothers: A phase 2 randomized, controlled trial

Clinical Infectious Diseases | Feb 07, 2018 Vaccine/Immunotherapy

« Prev 1 … 27 28 29 30 31 … 42 Next »

Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013–2014 season

Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013–2016

Impact of adverse event solicitation on the safety profile of SQ house dust mite sublingual immunotherapy tablet

Mogamulizumab (anti-CCR4) in HTLV-1–associated myelopathy

Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a previous dose

Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism

High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females

Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination

No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: Experience from a single centre

Safety and immunogenicity of newborn MVA85A vaccination and selective, delayed bacille Calmette-Guérin for infants of human immunodeficiency virus-infected mothers: A phase 2 randomized, controlled trial

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013–2014 season

Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013–2016

Impact of adverse event solicitation on the safety profile of SQ house dust mite sublingual immunotherapy tablet

Mogamulizumab (anti-CCR4) in HTLV-1–associated myelopathy

Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a previous dose

Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism

High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females

Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination

No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: Experience from a single centre

Safety and immunogenicity of newborn MVA85A vaccination and selective, delayed bacille Calmette-Guérin for infants of human immunodeficiency virus-infected mothers: A phase 2 randomized, controlled trial

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic